CYTEK BIOSCIENCES, INC. (CTKB) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$9.39M*; Operating income -$11.40M; Depreciation and amortization $2.01M*.
- 2026-03-31: Basis Reported; EBITDA -$16.6M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$3.7M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$7.27M*; Operating income -$9.19M; Depreciation and amortization $1.92M*.
Complete source-backed ebitda history.
- Available history
- 2020-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$9.39M* | -$11.40M | $2.01M* | $48.14M | -19.51%* | $2.22M* | $1.37M* | $19.80M | $9.74M | (m) | $515.00K |
|---|
| 2026-03-31 | Reported | -$16.6M | (m) | (m) | (m) | -37.61% | $2.17M | -$2.74M | $22.88M | $9.60M | (m) | $1.49M |
|---|
| 2025-12-31 | Reported | -$3.7M | (m) | (m) | (m) | -5.95% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$7.27M* | -$9.19M | $1.92M* | $52.29M | -13.91%* | $657.00K* | -$3.90M* | $24.74M | $8.96M | (m) | -$2.29M |
|---|
| 2025-06-30 | Reported | -$8.73M* | -$10.62M | $1.89M* | $45.60M | -19.15%* | $1.58M* | $108.00K* | $21.73M | $8.83M | (m) | -$1.19M |
|---|
| 2025-03-31 | Reported | -$13.1M | (m) | (m) | (m) | -31.60% | $849.00K | -$125.00K | $21.30M | $9.72M | (m) | $136.00K |
|---|
| 2024-12-31 | Reported | $4.84M | (m) | (m) | (m) | 8.42% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$2.40M* | -$4.25M | $1.85M* | $51.50M | -4.65%* | $1.01M* | $13.22M* | $22.50M | $9.88M | (m) | -$784.00K |
|---|
| 2024-06-30 | Reported | -$6.72M* | -$8.53M | $1.81M* | $46.62M | -14.41%* | $1.05M* | $6.20M* | $21.18M | $10.00M | (m) | $3.25M |
|---|
| 2024-03-31 | Reported | -$9.04M | (m) | (m) | (m) | -20.14% | $567.00K | $3.96M | $21.85M | $9.80M | (m) | -$2.82M |
|---|
| 2023-12-31 | Reported | $1.49M | (m) | (m) | (m) | 2.57% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$4.65M* | -$6.42M | $1.77M* | $48.00M | -9.69%* | $1.33M* | -$4.24M* | $20.82M | $11.17M | (m) | $2.27M |
|---|
| 2023-06-30 | Reported | -$7.48M* | -$9.13M | $1.65M* | $49.69M | -15.05%* | $1.31M* | -$2.85M* | $21.53M | $12.14M | (m) | -$2.21M |
|---|
| 2023-03-31 | Reported | -$11.16M | (m) | (m) | (m) | -30.09% | $505.00K | $2.86M | $16.05M | $9.97M | (m) | -$2.23M |
|---|
| 2022-12-31 | Reported | $845,000.00 | (m) | (m) | (m) | 1.75% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | $1.43M* | $1.36M | $72.00K* | $40.48M | 3.54%* | $1.11M* | -$7.50M* | $13.62M | $8.65M | (m) | $224.00K |
|---|
| 2022-06-30 | Reported | -$26.00K* | -$891.00K | $865.00K* | $40.16M | -0.06%* | $1.33M* | -$9.44M* | $15.60M | $8.44M | (m) | -$699.00K |
|---|
| 2022-03-31 | Reported | -$1.56M | (m) | (m) | (m) | -4.46% | $780.00K | -$1.48M | $14.89M | $8.03M | (m) | -$1.15M |
|---|
| 2021-12-31 | Reported | $2M | (m) | (m) | (m) | 5.15% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | $3.09M* | $2.90M | $189.00K* | $34.38M | 8.98%* | $1.31M* | $1.16M* | $13.10M | $6.08M | (m) | $655.00K |
|---|
| 2021-06-30 | Reported | $4.01M* | $3.81M | $201.00K* | $30.41M | 13.19%* | $1.25M* | -$3.91M* | $10.66M | $6.19M | (m) | $597.00K |
|---|
| 2021-03-31 | Reported | $1.3M | (m) | (m) | (m) | 5.35% | $509.00K | $1.94M | $9.79M | $5.09M | (m) | $50.00K |
|---|
| 2020-12-31 | Reported | $8.03M | (m) | (m) | (m) | 26.24% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | $6.89M* | $6.71M | $179.00K* | $25.10M | 27.45%* | $474.00K* | $2.19M* | $9.48M | $3.38M | (m) | $357.00K |
|---|
| 2020-06-30 | Reported | (m) | -$218.00K | (m) | $19.14M | (m) | (m) | (m) | $10.87M | $2.92M | (m) | -$7.92M |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$32.81M | (m) | (m) | (m) | -16.28% | $4.08M | -$4.69M | $97.03M | $36.47M | (m) | $36.70M |
|---|
| 2024-12-31 | Reported | -$13.31M | (m) | (m) | (m) | -6.64% | $3.52M | $25.38M | $89.35M | $39.40M | (m) | $320.00K |
|---|
| 2023-12-31 | Reported | -$21.8M | (m) | (m) | (m) | -11.29% | $4.65M | $5.28M | $83.59M | $44.15M | (m) | -$3.56M |
|---|
| 2022-12-31 | Reported | $688,000.00 | (m) | (m) | (m) | 0.42% | $9.75M | -$12.23M | $63.06M | $34.86M | (m) | -$1.22M |
|---|
| 2021-12-31 | Reported | $10.4M | (m) | (m) | (m) | 8.13% | $4.36M | $4.63M | $48.81M | $24.44M | (m) | $2.91M |
|---|
| 2020-12-31 | Reported | $14.26M | (m) | (m) | (m) | 15.36% | $1.55M | $15.16M | $41.13M | $13.69M | (m) | -$4.98M |
|---|